Charlier, Bruno
 Distribuzione geografica
Continente #
AS - Asia 2.715
NA - Nord America 808
EU - Europa 563
SA - Sud America 101
AF - Africa 10
OC - Oceania 7
Continente sconosciuto - Info sul continente non disponibili 1
Totale 4.205
Nazione #
HK - Hong Kong 2.250
US - Stati Uniti d'America 784
SG - Singapore 248
IT - Italia 240
RU - Federazione Russa 125
CN - Cina 104
BR - Brasile 83
DE - Germania 58
VN - Vietnam 46
GB - Regno Unito 30
IN - India 24
FI - Finlandia 17
FR - Francia 17
IE - Irlanda 17
KR - Corea 14
PL - Polonia 14
MX - Messico 12
CA - Canada 11
ES - Italia 10
SE - Svezia 10
JP - Giappone 9
AT - Austria 8
AU - Australia 7
EC - Ecuador 7
NL - Olanda 7
TR - Turchia 7
AR - Argentina 6
UA - Ucraina 4
ZA - Sudafrica 4
BD - Bangladesh 3
KE - Kenya 2
MY - Malesia 2
VE - Venezuela 2
A2 - ???statistics.table.value.countryCode.A2??? 1
BA - Bosnia-Erzegovina 1
BE - Belgio 1
BG - Bulgaria 1
BN - Brunei Darussalam 1
BW - Botswana 1
CO - Colombia 1
CZ - Repubblica Ceca 1
DZ - Algeria 1
EE - Estonia 1
EG - Egitto 1
HN - Honduras 1
IQ - Iraq 1
IR - Iran 1
KG - Kirghizistan 1
LB - Libano 1
LT - Lituania 1
NP - Nepal 1
PY - Paraguay 1
SA - Arabia Saudita 1
TZ - Tanzania 1
UY - Uruguay 1
UZ - Uzbekistan 1
Totale 4.205
Città #
Hong Kong 2.243
Dallas 148
Singapore 107
Chandler 93
Ashburn 72
Princeton 50
Munich 47
Ann Arbor 45
Naples 45
Beijing 31
Los Angeles 25
New York 22
Dong Ket 17
Dublin 17
Salerno 17
Rome 16
Woodbridge 15
Moscow 14
Redwood City 14
Jacksonville 13
Mercato San Severino 13
Pune 13
São Paulo 13
Turku 13
Warsaw 13
Wokingham 13
Fisciano 11
Hanoi 10
Ho Chi Minh City 10
Council Bluffs 9
Seattle 9
Stockholm 9
Wilmington 8
Brooklyn 6
Houston 6
Montpellier 6
San Prisco 6
Tokyo 6
Adelaide 5
Amsterdam 5
Chennai 5
Denver 5
Francavilla Fontana 5
Guangzhou 5
Izmir 5
Palermo 5
Santa Clara 5
Seoul 5
Tianjin 5
Valencia 5
Andover 4
Aversa 4
Boardman 4
Glasgow 4
London 4
Mexico City 4
Milan 4
Montreal 4
Norwalk 4
Nuremberg 4
Ottawa 4
Phoenix 4
Quito 4
Rio de Janeiro 4
San Francisco 4
The Dalles 4
Verona 4
Arba 3
Bologna 3
Caserta 3
Chicago 3
Fairfield 3
Hebei 3
Johannesburg 3
Nanchang 3
Nanjing 3
Napoli 3
Novate Milanese 3
Orem 3
Richmond 3
Washington 3
Atlanta 2
Belo Horizonte 2
Betim 2
Boston 2
Brasília 2
Cambridge 2
Carney 2
Chuo 2
Duncan 2
Grand Rapids 2
Guayaquil 2
Helsinki 2
Itajaí 2
L'aquila 2
Lappeenranta 2
Manchester 2
Nagold 2
Nairobi 2
Ottaviano 2
Totale 3.433
Nome #
A UHPLC-MS/MS-based method for the simultaneous monitoring of eight antiblastic drugs in plasma and urine of exposed healthcare workers 757
Development and Validation of a Reverse-Phase High-Performance Liquid Chromatography with Fluorescence Detection (RP-HPLC-FL) Method to Quantify Ruxolitinib in Plasma Samples 557
Antioxidant Supplementation Hinders the Role of Exercise Training as a Natural Activator of SIRT1 396
Effects of selected preanalytical variables on Dried Blood Spot (DBS) and Volumetric Adsorptive Microsampling (VAMS) based bioanalytical methods for the determination of four β-lactam antibiotics 219
Come rendere un ospedale formaldeide free 199
In Vitro Evaluation of Antibacterial and Antibiofilm Activity of Different Chlorhexidine-Containing Mouthwash Formulations against Streptococcus mutans 191
Standard addition method (SAM) in LC-MS/MS to quantify gluten-derived metabolites in urine samples 162
Bone marrow mesenchymal stem cells as a possible ruxolitinib reservoir in the bone marrow niche 158
A genotyping/phenotyping approach with careful clinical monitoring to manage the fluoropyrimidines-based therapy: Clinical cases and systematic review of the literature 149
Chemical risk in hospital settings: Overview on monitoring strategies and international regulatory aspects 113
Development and Validation of a New LC-MS/MS Bioanalytical Method for the Simultaneous Determination of Levodopa, Levodopa Methyl Ester, and Carbidopa in Human Plasma Samples 100
Health status and concomitant prescription of immunosuppressants are risk factors for hydroxychloroquine non-adherence in systemic lupus patients with prolonged inactive disease 99
Development of a novel ion-pairing HPLC-FL method for the separation and quantification of hydroxychloroquine and its metabolites in whole blood 99
BONE MARROW MESENCHYMAL STEM CELLS AS FACILITATOR OF RUXOLITINIB-MEDIATED INHIBITION OF JAK2 MUTADED CELLS 91
Development and Validation of a UHPLC–MS/MS-Based Method to Quantify Cenobamate in Human Plasma Samples 89
Therapeutic drug monitoring might identify poor responders to ruxolitinib treatment in myeloproliferative neoplasms 87
Perampanel dosage in plasma samples: development and validation of a novel HPLC method with combined UV-Fluorescence detection 87
Environmental and biological monitoring of formaldehyde inside a hospital setting: a combined approach to manage chemical risk in workplaces 86
Microbial-derived bile acid reverses inflammation in IBD via GPBAR1 agonism and RORγt inverse agonism 84
Novel Drug Targets for the Treatment of Cardiac Diseases 84
A LC-MS/MS based methodology for the environmental monitoring of healthcare settings contaminated with antineoplastic agents 75
The Effect of Plasma Protein Binding on the Therapeutic Monitoring of Antiseizure Medications 72
Bioconversion of 4-hydroxyestradiol by extradiol ring-cleavage dioxygenases from Novosphingobium sp. PP1Y 68
Lipid nano-vesicles for thyroid hormone encapsulation: A comparison between different fabrication technologies, drug loading, and an in vitro delivery to human tendon stem/progenitor cells in 2D and 3D culture 64
Gender Differences in Levodopa Pharmacokinetics in Levodopa-Naïve Patients With Parkinson's Disease 60
Pharmacological Treatments and Therapeutic Drug Monitoring in Patients with Chronic Pain 43
Ticagrelor 60 vs. 90 mg in elderly ACS patients undergoing PCI: a randomized, crossover trial 33
Quantitative Analysis of Cenobamate and Concomitant Anti-Seizure Medications in Human Plasma via Ultra-High Performance Liquid Chromatography–Tandem Mass Spectrometry 33
Clinical predictors and concomitant antiseizure medications effects on seizure control in relation to plasma cenobamate concentration: a multicenter retrospective study 10
Totale 4.265
Categoria #
all - tutte 12.328
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 12.328


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021137 0 0 0 0 25 5 20 7 19 25 10 26
2021/202297 1 12 0 3 6 5 3 6 5 6 12 38
2022/2023249 15 33 37 32 17 40 6 18 30 0 6 15
2023/2024191 20 17 9 13 23 38 11 12 4 8 15 21
2024/2025536 4 12 9 16 37 42 121 30 77 23 67 98
2025/20262.901 138 1.359 1.036 185 183 0 0 0 0 0 0 0
Totale 4.265